The January-March quarter (fourth quarter, or Q4) results of the largest listed players in the diagnostic space do not portray a healthy picture. Competitive pressures, weak organic growth, integration challenges, and higher costs injured the operational performance of companies in the sector.
In light of the above, brokerages have slashed their earnings estimates for the three large listed players Dr. Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies 15-20 per cent.
If Q4 results of 2021-22 are any indication, growth is going to be a near-term challenge for the sector.
The country's largest listed player Dr. Lal PathLabs - reported a sequential decline in revenue, excluding Coviddriven business. The base business (like-for-like) was up 4.4 per cent over the year ago quarter, compared to the two-year average annual growth of under 14 per cent.
Rahul Jeevani and Punit Pujara of IIFL Securities have downgraded the company's 2022-23 (FY23)/2023-24 (FY24) earnings per share (EPS) by 15 per cent since non-Covid organic revenue growth of 9 per cent (three-year average growth) has remained below pre-Covid growth rates of 14-15 per cent.
Denne historien er fra May 30, 2022-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra May 30, 2022-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
A global outreach beyond business
An ancient civilisation with a modern outlook, India has a lot of fine strengths – in cinema, sports, art, culture, food, yoga – that it is building on
Union Carbide waste disposal: Protests rock Pithampur, 2 attempt self-immolation
Two persons on Friday attempted self-immolation, adding to tensions in Pithampur, Madhya Pradesh, as protests against the planned disposal of 337 tonnes of hazardous waste from Bhopal's defunct Union Carbide factory continued in the small industrial town.
Over 500 flights delayed, 24 train ops hit in Delhi
Palam airport records zero visibility from 8 am to 9.30 am Friday
AFTER SINDHU, WHO?
Women's badminton faces uncertainty due to a shrinking talent pool, lack of quality coaches, and overreliance on Gopichand
No cause for alarm: Indian health officials on hMPV spread in China
As the world marks the fifth anniversary of the Covid-19 pandemic in 2025, another flu-like illness has emerged, though Indian officials insist there is no reason to panic.
Jefferies: '25 may be year of monetary easing in India
Brokerage raises target price for HDFC, ICICI Bank
Avenue Supermarts hits 15% upper circuit after Q3 update
Avenue Supermarts (owner of DMart retail chain) shares clocked 15 per cent upper circuit in trade on BSE at ₹4,160.4 per share on Friday. Buying in the stock sparked after the company released its Q3 business update.
Film producer Vipul Shah's Sunshine Pictures files DRHP
Film and television producer-director Vipul Shah-backed Sunshine Pictures has filed draft papers with the market regulator Sebi to raise funds through an initial public offering (IPO).
MFs' Equity Buying Topped ₹4 Trillion in 2024
Mutual funds' (MFs) equity buying jumped over twofold in 2024 to top ₹4 trillion for the first time.
Quadrant Future fixes price band at ₹275-290, offer opens on Jan 7
Quadrant Future Tek on Friday said it has fixed the price band at ₹275-290 per equity share for its ₹290-crore initial public offering (IPO) that will open for public subscription on January 7.
